Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2019 Volume 20 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2019 Volume 20 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1

  • Authors:
    • Ling Tang
    • Wenjun Lu
    • Jian Huang
    • Xu Tang
    • Huiyun Zhang
    • Shujiao Liu
  • View Affiliations / Copyright

    Affiliations: Department of Geriatrics, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China, Department of Cell Biology and Genetics, Guilin Medical University, Guilin, Guangxi 541005, P.R. China, Department of Occupational and Environmental Health, School of Public Health, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Endocrinology, Graduate School of Guilin Medical University, Guilin, Guangxi 541001, P.R. China
    Copyright: © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 270-280
    |
    Published online on: May 16, 2019
       https://doi.org/10.3892/mmr.2019.10252
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteoporosis (OP) seriously affects the health and quality of life of elderly individuals and postmenopausal women, and the need to identify drugs that can prevent or treat OP remains urgent. Recently, several miRNAs have been reported to be involved in the differentiation of mesenchymal stem cells and osteoblasts; however, the role of miRNA (miR)‑144 in regulating OP remains to be elucidated. In the present study, the expression levels of miR‑144, secreted frizzled‑related protein 1 (Sfrp1) and TNF‑α in clinical samples were detected by the reverse transcription‑quantitative polymerase chain reaction analysis and ELISA, respectively. 5‑Ethynyl‑2'‑deoxyuridine staining, Hoechst 33258 staining, flow cytometry, a clone formation assay and Alizarin red staining were used to assess the effects of miR‑144 combined with or without Sfrp1 small interfering RNA on the proliferation, apoptosis and osteoblastic differentiation of primary mesenchymal stem cells isolated from rats. Western blot assays were performed to assess the relevant mechanisms, and a dual luciferase reporter assay was used to detect the interaction between miR‑144 and Sfrp1. The results showed that the levels of miR‑144, Sfrp1 and TNF‑α in clinical serum samples obtained from patients with postmenopausal OP were higher than those in serum samples obtained from postmenopausal women with normal bone density. There was a significant positive correlation between miR‑144 and Sfrp1. Functional experiments demonstrated that miR‑144 promoted proliferation, inhibited apoptosis and induced the osteoblastic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sfrp1. It was also shown that miR‑144 may help regulate OP by activating the Wnt/β‑catenin pathway. These data suggest miR‑144 as a novel target for preventing and treating OP.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Janiszewska M, Kulik T, Żołnierczuk-Kieliszek D, Drop B, Firlej E and Gajewska I: General self-efficacy level and health behaviours in women over the age of 45 years who have undergone osteoporosis treatment. Prz Menopauzalny. 16:86–95. 2017.PubMed/NCBI

2 

Baron R and Gori F: Targeting WNT signaling in the treatment of osteoporosis. Curr Opin Pharmacol. 40:134–141. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Rizou S, Chronopoulos E, Ballas M and Lyritis GP: Clinical manifestations of osteoarthritis in osteoporotic and osteopenic postmenopausal women. J Musculoskelet Neuronal Interact. 18:208–214. 2018.PubMed/NCBI

4 

Nguyen BN, Hoshino H, Togawa D and Matsuyama Y: Cortical thickness index of the proximal femur: A radiographic parameter for preliminary assessment of bone mineral density and osteoporosis status in the age 50 years and over population. Clin Orthop Surg. 10:149–156. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Han Y, You X, Xing W, Zhang Z and Zou W: Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts. osteocytes, and osteoclasts. Bone Res. 6:162018. View Article : Google Scholar : PubMed/NCBI

6 

Gómez-Cerezo N, Casarrubios L, Morales I, Feito MJ, Vallet-Regí M, Arcos D and Portolés MT: Effects of a mesoporous bioactive glass on osteoblasts, osteoclasts and macrophages. J Colloid Interface Sci. 528:309–320. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Mödinger Y, Löffler B, Huber-Lang M and Ignatius A: Complement involvement in bone homeostasis and bone disorders. Semin Immunol. 37:53–65. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Zhang RF, Wang Q, Zhang AA, Xu JG, Zhai LD, Yang XM and Liu XT: Low-level laser irradiation promotes the differentiation of bone marrow stromal cells into osteoblasts through the APN/Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci. 22:2860–2868. 2018.PubMed/NCBI

9 

Wang R, Xu B and Xu HG: Up-Regulation of TGF-β promotes Tendon-to-Bone healing after anterior cruciate ligament reconstruction using Bone Marrow-Derived mesenchymal stem cells through the TGF-β/MAPK signaling pathway in a New Zealand White Rabbit model. Cell Physiol Biochem. 41:213–226. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Xu R, Shi G, Xu L, Gu Q, Fu Y, Zhang P, Cheng J and Jiang H: Simvastatin improves oral implant osseointegration via enhanced autophagy and osteogenesis of BMSCs and inhibited osteoclast activity. J Tissue Eng Regen Med. 12:1209–1219. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Fan JZ, Yang L, Meng GL, Lin YS, Wei BY, Fan J, Hu HM, Liu YW, Chen S, Zhang JK, et al: Estrogen improves the proliferation and differentiation of hBMSCs derived from postmenopausal osteoporosis through notch signaling pathway. Mol Cell Biochem. 392:85–93. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Qiu J, Huang G, Na N and Chen L: MicroRNA-214-5p/TGF-β/Smad2 signaling alters adipogenic differentiation of bone marrow stem cells in postmenopausal osteoporosis. Mol Med Rep. 17:6301–6310. 2018.PubMed/NCBI

13 

Abdi J, Mutis T, Garssen J and Redegeld FA: Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis. PLoS One. 9:e966082014. View Article : Google Scholar : PubMed/NCBI

14 

Sárközy M, Kahán Z and Csont T: A myriad of roles of miR-25 in health and disease. Oncotarget. 9:21580–21612. 2018. View Article : Google Scholar : PubMed/NCBI

15 

Casciaro M, Di Salvo E, Brizzi T, Rodolico C and Gangemi S: Involvement of miR-126 in autoimmune disorders. Clin Mol Allergy. 16:112018. View Article : Google Scholar : PubMed/NCBI

16 

Pan Y, Jing J, Qiao L, Liu J, An L, Li B, Ren D and Liu W: MiRNA-seq reveals that miR-124-3p inhibits adipogenic differentiation of the stromal vascular fraction in sheep via targeting C/EBPα. Domest Anim Endocrinol. 65:17–23. 2018. View Article : Google Scholar : PubMed/NCBI

17 

Huang C, Yu M and Yao X: MicroRNA-17 and the prognosis of human carcinomas: A systematic review and meta-analysis. BMJ Open. 8:e0180702018. View Article : Google Scholar : PubMed/NCBI

18 

Lopez-Santillan M, Larrabeiti-Etxebarria A, Arzuaga-Mendez J, Lopez-Lopez E and Garcia-Orad A: Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review. Oncotarget. 9:22850–22861. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Hu X, Tang J, Hu X, Bao P, Pan J, Chen Z and Xian J: MiR-27b impairs adipocyte differentiation of human adipose tissue-derived mesenchymal stem cells by targeting LPL. Cell Physiol Biochem. 47:545–555. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Dai F, Du P, Chang Y, Ji E, Xu Y, Wei C and Li J: Downregulation of MiR-199b-5p inducing differentiation of bone-marrow mesenchymal stem cells (BMSCs) toward Cardiomyocyte-Like cells via HSF1/HSP70 pathway. Med Sci Monit. 24:2700–2710. 2018. View Article : Google Scholar : PubMed/NCBI

21 

Teng Z, Xie X, Zhu Y, Liu J, Hu X, Na Q, Zhang X, Wei G, Xu S, Liu Y, et al: miR-142-5p in bone marrow-derived mesenchymal stem cells promotes osteoporosis involving targeting adhesion molecule VCAM-1 and Inhibiting cell migration. Biomed Res Int. 2018:32746412018. View Article : Google Scholar : PubMed/NCBI

22 

Feichtinger X, Muschitz C, Heimel P, Baierl A, Fahrleitner-Pammer A, Redl H, Resch H, Geiger E, Skalicky S, Dormann R, et al: Bone-related circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to bone microstructure and histomorphometry. Sci Rep. 8:48672018. View Article : Google Scholar : PubMed/NCBI

23 

Liu Y, Xu F, Pei HX, Zhu X, Lin X, Song CY, Liang QH, Liao EY and Yuan LQ: Vaspin regulates the osteogenic differentiation of MC3T3-E1 through the PI3K-Akt/miR-34c loop. Sci Rep. 6:255782016. View Article : Google Scholar : PubMed/NCBI

24 

Tang X, Lin J, Wang G and Lu J: MicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expression. PLoS One. 12:e01798602017. View Article : Google Scholar : PubMed/NCBI

25 

Han S, Zhu J and Zhang Y: MiR-144 potentially suppresses proliferation and migration of ovarian cancer cells by targeting RUNX1. Med Sci Monit Basic Res. 24:40–46. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Tao P, Wen H, Yang B, Zhang A, Wu X and Li Q: MiR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC. Exp Ther Med. 15:562–568. 2018.PubMed/NCBI

27 

Liu J, Feng L, Zhang H, Zhang J, Zhang Y, Li S, Qin L, Yang Z and Xiong J: Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation. Cancer Biol Ther. 19:484–4962. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Ren YF, Zhang TH, Zhong S, Zhao YT and Lv YN: MiR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression. Oncol Lett. 15:1163–1169. 2018.PubMed/NCBI

29 

Hou Q, Huang Y, Zhu S, Li P, Chen X, Hou Z and Liu F: MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1. Cell Physiol Biochem. 44:2256–2268. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Xiang C, Cui SP and Ke Y: MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR. J Huazhong Univ Sci Technolog Med Sci. 36:186–192. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Wu M, Chen G and Li YP: TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 4:160092016. View Article : Google Scholar : PubMed/NCBI

32 

Nakajima K, Kho DH, Yanagawa T, Harazono Y, Gao X, Hogan V and Raz A: Galectin-3 inhibits osteoblast differentiation through notch signaling. Neoplasia. 16:939–949. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Duan P and Bonewald LF: The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth. Int J Biochem Cell Biol. 77:23–29. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Cao F, Zhan J, Chen X, Zhang K, Lai R and Feng Z: MiR-214 promotes periodontal ligament stem cell osteoblastic differentiation by modulating Wnt/β-catenin signaling. Mol Med Rep. 16:9301–9308. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Dejaeger M, Böhm AM, Dirckx N, Devriese J, Nefyodova E, Cardoen R, St-Arnaud R, Tournoy J, Luyten FP and Maes C: Integrin-Linked kinase regulates bone formation by controlling cytoskeletal organization and modulating BMP and Wnt signaling in osteoprogenitors. J Bone Miner Res. 32:2087–2102. 2017. View Article : Google Scholar : PubMed/NCBI

36 

Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R and Dharmarajan A: sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease. Int J Biochem Cell Biol. 75:104–111. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Amjadi-Moheb F, Hosseini SR, Kosari-Monfared M, Ghadami E, Nooreddini H and Akhavan-Niaki H: A specific haplotype in potential miRNAs binding sites of secreted frizzled-related protein 1 (SFRP1) is associated with BMD variation in osteoporosis. Gene. 677:132–141. 2018. View Article : Google Scholar : PubMed/NCBI

38 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

39 

Chim CS, Pang R, Fung TK, Choi CL and Liang R: Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Leukemia. 21:2527–2536. 2007. View Article : Google Scholar : PubMed/NCBI

40 

Shen G, Ren H, Qiu T, Zhang Z, Zhao W, Yu X, Huang J, Tang J, Liang, Yao Z, et al: Mammalian target of rapamycin as a therapeutic target in osteoporosis. J Cell Physiol. 233:3929–3944. 2018. View Article : Google Scholar : PubMed/NCBI

41 

Li X, Ji J, Wei W and Liu L: MiR-25 promotes proliferation, differentiation and migration of osteoblasts by up-regulating Rac1 expression. Biomed Pharmacother. 99:622–628. 2018. View Article : Google Scholar : PubMed/NCBI

42 

Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang W, Jafferji M, Gordon JA, Li Z, Croce CM, van Wijnen AJ, Stein JL, et al: MiR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI

43 

Holdsworth G, Greenslade K, Jose J, Stencel Z, Kirby H, Moore A, Ke HZ and Robinson MK: Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists. Bone. 107:93–103. 2018. View Article : Google Scholar : PubMed/NCBI

44 

Wang FS, Lin CL, Chen YJ, Wang CJ, Yang KD, Huang YT, Sun YC and Huang HC: Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology. 146:2415–2423. 2005. View Article : Google Scholar : PubMed/NCBI

45 

Wang C, Liao H and Cao Z: Role of Osterix and MicroRNAs in bone formation and tooth development. Med Sci Monit. 22:2934–2942. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Stewart S, Gomez AW, Armstrong BE, Henner A and Stankunas K: Sequential and opposing activities of Wnt and BMP coordinate zebrafish bone regeneration. Cell Rep. 6:482–498. 2014. View Article : Google Scholar : PubMed/NCBI

47 

Fujita M, Urano T, Horie K, Ikeda K, Tsukui T, Fukuoka H, Tsutsumi O, Ouchi Y and Inoue S: Estrogen activates cyclin-dependent kinases 4 and 6 through induction of cyclin D in rat primary osteoblasts. Biochem Biophys Res Commun. 299:222–228. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tang L, Lu W, Huang J, Tang X, Zhang H and Liu S: miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1. Mol Med Rep 20: 270-280, 2019.
APA
Tang, L., Lu, W., Huang, J., Tang, X., Zhang, H., & Liu, S. (2019). miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1. Molecular Medicine Reports, 20, 270-280. https://doi.org/10.3892/mmr.2019.10252
MLA
Tang, L., Lu, W., Huang, J., Tang, X., Zhang, H., Liu, S."miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1". Molecular Medicine Reports 20.1 (2019): 270-280.
Chicago
Tang, L., Lu, W., Huang, J., Tang, X., Zhang, H., Liu, S."miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1". Molecular Medicine Reports 20, no. 1 (2019): 270-280. https://doi.org/10.3892/mmr.2019.10252
Copy and paste a formatted citation
x
Spandidos Publications style
Tang L, Lu W, Huang J, Tang X, Zhang H and Liu S: miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1. Mol Med Rep 20: 270-280, 2019.
APA
Tang, L., Lu, W., Huang, J., Tang, X., Zhang, H., & Liu, S. (2019). miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1. Molecular Medicine Reports, 20, 270-280. https://doi.org/10.3892/mmr.2019.10252
MLA
Tang, L., Lu, W., Huang, J., Tang, X., Zhang, H., Liu, S."miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1". Molecular Medicine Reports 20.1 (2019): 270-280.
Chicago
Tang, L., Lu, W., Huang, J., Tang, X., Zhang, H., Liu, S."miR‑144 promotes the proliferation and differentiation of bone mesenchymal stem cells by downregulating the expression of SFRP1". Molecular Medicine Reports 20, no. 1 (2019): 270-280. https://doi.org/10.3892/mmr.2019.10252
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team